Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib with Chemoradiotherapy in HNSCC
NCT00229723Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of gefitinib in head and neck squamous cell carcinoma (HNSCC), sponsored by AstraZeneca. Started Nov 2004; status: completed.
02
Drugs
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00229723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229723.